United Kingdom · Question · Written question
UIN 9535
Motor Neurone Disease: Aldesleukin
Original
Introduced
16 October 2024
Last action
22 October 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 October 2024
Summary
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of making Proleukin available for motor neurone disease patients on the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 October 2024
Written question
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of making Proleukin available for motor neurone disease patients on the NHS.
Source: Commons
22 October 2024
Answer
We have made no assessment. It is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products R...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-10-16/9535
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1734801
- uk · wq-1734801 · source updated 22 October 2024